Healthcare / Distribution · Closed (control transfer)
Pátria closes sale of 99.56% voting control of Elfa Medicamentos
- Acquirer
- Gravataí Participações
- Target
- Elfa Medicamentos (from Pátria funds)
- Est. deal value
- $120.3M / R$ 620,5 mi
- Timestamp
- 58 days ago · 24 Aug 2026, 09:52 BRT
Highlights & source
Elfa told the market on Monday that control passed from Pátria-managed funds to Gravataí Participações after a statutory liquidity event converted preferred shares. Buyer will ask CVM to waive a mandatory tag-along tender and says it will not cancel the public-company registration within one year.
Valor cites an acquisition price of R$ 620.49 million paid proportionally to selling Pátria funds (USD converted at window FX 5.16). Earnout if Gravataí sells Elfa within 36 months. Confirm unit against the CVM filing.
Source: Valor Econômico
24 Aug 2026, 09:52 BRT · 24 Aug 2026, 12:52 UTC
